| [1] |
Dian S, Ganiem AR, van Laarhoven A. Central nervous system tuberculosis. Curr Opin Neurol, 2021, 34(3):396-402. doi:10.1097/WCO.0000000000000920.
pmid: 33661159
|
| [2] |
Streptomycin in Tuberculosis Trials Commitee, Medical Research Council. Streptomycin treatment of tuberculous meningitis. Lancet, 1948, 251(6503): 582-596. doi:10.1016/S0140-6736(48)92003-0.
|
| [3] |
中华医学会结核病学分会结核性脑膜炎专业委员会. 2019中国中枢神经系统结核病诊疗指南. 中华传染病杂志, 2020, 38(7):400-408. doi:10.3760/cma.j.cn311365-20200606-00645.
|
| [4] |
Rock RB, Olin M, Baker CA, et al. Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev, 2008, 21(2):243-261, table of contents. doi:10.1128/CMR.00042-07.
pmid: 18400795
|
| [5] |
Navarro-Flores A, Fernandez-Chinguel JE, Pacheco-Barrios N, et al. Global morbidity and mortality of central nervous system tuberculosis: a systematic review and meta-analysis. J Neurol, 2022, 269(7):3482-3494. doi:10.1007/s00415-022-11052-8.
pmid: 35288778
|
| [6] |
Singh AK, Malhotra HS, Garg RK, et al. Paradoxical reaction in tuberculous meningitis: presentation, predictors and impact on prognosis. BMC Infect Dis, 2016, 16:306. doi:10.1186/s12879-016-1625-9.
pmid: 27329253
|
| [7] |
Tai MS, Nor HM, Kadir KAA, et al. Paradoxical Manifestation is Common in HIV-negative Tuberculous Meningitis. Medicine (Baltimore), 2016, 95(1):e1997. doi:10.1097/MD.0000000000001997.
|
| [8] |
Barnacle JR, Davis AG, Wilkinson RJ. Recent advances in understanding the human host immune response in tuberculous meningitis. Front Immunol, 2024, 14: 1326651. doi:10.3389/fimmu.2023.1326651.
|
| [9] |
Thuong NTT, Thwaites GE. Treatment-Associated Inflammatory Deterioration in Tuberculous Meningitis: Unpicking the Paradox. J Infect Diseases, 2017, 215(5):665-667. doi:10.1093/infdis/jiw565.
|
| [10] |
Jha SK, Garg RK, Jain A, et al. Definite (microbiologically confirmed) tuberculous meningitis: predictors and prognostic impact. Infection, 2015, 43(6):639-645. doi:10.1007/s15010-015-0756-z.
pmid: 25724799
|
| [11] |
Bahr NC, Boulware DR. Methods of rapid diagnosis for the etiology of meningitis in adults. Biomark Med, 2014, 8(9):1085-1103. doi:10.2217/bmm.14.67.
pmid: 25402579
|
| [12] |
Teoh R, O’Mahony G, Yeung VT. Polymorphonuclear pleocytosis in the cerebrospinal fluid during chemotherapy for tuberculous meningitis. J Neurol, 1986, 233(4):237-241. doi:10.1007/BF00314027.
pmid: 3746363
|
| [13] |
Sütlaş PN, Unal A, Forta H, et al. Tuberculous meningitis in adults: review of 61 cases. Infection, 2003, 31(6):387-391. doi:10.1007/s15010-003-3179-1.
pmid: 14735380
|
| [14] |
Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med, 2004, 351(17):1741-1751. doi:10.1056/NEJMoa040573.
|
| [15] |
中国人民解放军总医院第八医学中心结核病医学部/全军结核病研究所/全军结核病防治重点实验室/结核病诊疗新技术北京市重点实验室, 《中国防痨杂志》编辑委员会. 糖皮质激素在结核病治疗中的合理应用专家共识. 中国防痨杂志, 2022, 44(1):28-37. doi:10.19982/j.issn.1000-6621.20210683.
|
| [16] |
Schoeman JF, Springer P, van Rensburg AJ, et al. Adjunctive thalidomide therapy for childhood tuberculous meningitis: results of a randomized study. J Child Neurol, 2004, 19(4):250-257. doi:10.1177/088307380401900402.
pmid: 15163089
|
| [17] |
Keddie S, Bharambe V, Jayakumar A, et al. Clinical perspectives into the use of thalidomide for central nervous system tuberculosis. Eur J Neurol, 2018, 25(11):1345-1351. doi:10.1111/ene.13732.
pmid: 29935038
|
| [18] |
Tsenova L, Mangaliso B, Muller G, et al. Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis. Antimicrob Agents Chemother, 2002, 46(6):1887-1895. doi:10.1128/AAC.46.6.1887-1895.2002.
|
| [19] |
黄永锋. 中枢神经系统感染性疾病患者脑脊液细胞因子变化情况研究. 陕西医学杂志, 2016, 45(7):850-852. doi:10.3969/j.issn.1000-7377.2016.07.32.
|
| [20] |
Ginalis EE, Fernández LL, Ávila JP, et al. A review of external lumbar drainage for the management of intracranial hypertension in traumatic brain injury. Neurochirurgie, 2022, 68(2):206-211. doi:10.1016/j.neuchi.2021.05.004.
|
| [21] |
陈宇, 樊丽超, 陈禹, 等. 持续腰大池引流术在结核性脑膜炎治疗中的应用. 结核病与肺部健康杂志, 2018, 7(3):221-224. doi:10.3969/j.issn.2095-3755.2018.03.016.
|
| [22] |
孟艺哲, 韩玮欣, 李军霞, 等. 腰大池置管持续引流治疗重症结核性脑膜炎临床分析. 结核与肺部疾病杂志, 2022, 3(6):496-500. doi:10.19983/j.issn.2096-8493.20220041.
|
| [23] |
李伟, 王勇. 腰大池置管引流在结核性脑膜炎治疗中的应用效果. 中国继续医学教育, 2019, 11(4):92-94. doi:10.3969/j.issn.1674-9308.2019.04.042.
|
| [24] |
Berning SE, Cherry TA, Iseman MD, et al. Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: case report. Clin Infect Dis, 2001, 32(4):643-646. doi:10.1086/318698.
pmid: 11181130
|
京公网安备11010202007215号
ip访问总数: ip当日访问总数: 当前在线人数:
本作品遵循Creative Commons Attribution 3.0 License授权许可
